XETRA - Delayed Quote EUR

Vertex Pharmaceuticals Incorporated (VX1.DE)

386.40

+13.55

+(3.63%)

At close: 5:35:43 PM GMT+2

Are Investors Making a Big Mistake Dumping Shares of CRISPR Therapeutics?

CRISPR Therapeutics has an approved gene-therapy treatment still in its early growth stages. One of them is CRISPR Therapeutics (NASDAQ: CRSP). Its financials haven't been looking all that impressive and as a result, growth investors have been dumping the stock.

Motley Fool yesterday

CRSP

VRTX
Q1 Therapeutics Earnings: United Therapeutics (NASDAQ:UTHR) Impresses

As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the therapeutics industry, including United Therapeutics (NASDAQ:UTHR) and its peers.

StockStory yesterday

UTHR

ABBV

SRPT
2 Biotech Stocks That Are Screaming Buys in May

Two biotech stocks make perfect candidates for this sort of strategy right now. Let's take a close look at these two biotech stocks that are screaming buys in May. The launch and revenue growth processes take longer for such a product than for standard medicines because gene editing involves several steps.

Motley Fool 2 days ago

CRSP

VRTX
This Stock Just Dropped by 12% in 1 Day. History Says This Will Happen Next

Vertex Pharmaceuticals' shares dropped due to poor first-quarter results. Vertex's business and prospects remain attractive. Vertex Pharmaceuticals (NASDAQ: VRTX), a leading drugmaker, is performing exceedingly well for the year -- or at least it was, until it released its first-quarter update.

Motley Fool 2 days ago

VRTX
Prediction: These 2 Stocks Will Outperform the Market in the Next Five Years

Vertex Pharmaceuticals is diversifying its already strong lineup of medicines. Axsome Therapeutics has multiple clinical and regulatory catalysts on the way. Two excellent candidates are Vertex Pharmaceuticals (NASDAQ: VRTX) and Axsome Therapeutics (NASDAQ: AXSM).

Motley Fool 3 days ago

VRTX

AXSM
Can Buying CRISPR Therapeutics and Holding It Forever Make You a Millionaire?

The company has shown its revolutionary technology can deliver life-changing therapies. Now, it's about whether CRISPR Therapeutics can replicate the success across its promising pipeline.

Motley Fool 3 days ago

CRSP

VRTX
Is Vertex Pharmaceuticals (VRTX) Among the Best Stocks to Buy According to Jim Simons’ Renaissance Technologies?

We recently published a list of 15 Best Stocks to Buy According to Jim Simons’ Renaissance Technologies In this article, we are going to take a look at where Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) stands against other best stocks to buy according to Jim Simons’ Renaissance Technologies. Even after his passing in 2024, billionaire investor and […]

Insider Monkey 3 days ago

VRTX
My Favorite Tariff Safe-Haven Stock to Buy on the Dip

Recently, investors have worried about the impact of the U.S.’s import tariffs on corporate earnings. Certain companies that don’t heavily depend on imports from countries such as China may not suffer from President Trump’s tariff plan. What's driven this negative momentum is investors' concerns about the potential impact of import tariffs on corporate earnings.

Motley Fool 5 days ago

VRTX

^GSPC
Vertex Pharmaceuticals Incorporated (VRTX) Surged On a Recovery in Investor Sentiment

Baron Funds, an investment management company, released its “Baron Health Care Fund” first quarter 2025 investor letter. A copy of the letter can be downloaded here. The fund returned 2.54% (Institutional Shares) in the quarter compared to a 3.87% gain for the Russell 3000 Health Care Index (benchmark) and a 4.72% decline for the Russell […]

Insider Monkey 6 days ago

VRTX
Vertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should Know

Recently, Zacks.com users have been paying close attention to Vertex (VRTX). This makes it worthwhile to examine what the stock has in store.

Zacks 6 days ago

VRTX
Vertex Pharmaceuticals Incorporated Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

It's shaping up to be a tough period for Vertex Pharmaceuticals Incorporated ( NASDAQ:VRTX ), which a week ago released...

Simply Wall St. 6 days ago

VRTX
4 No-Brainer Stocks to Buy Right Now

The current volatile situation shouldn't preclude investors from buying stocks. Eli Lilly, Vertex, Meta Platforms, and Netflix all stand to enjoy solid growth. Market volatility and near-term uncertainty can be challenging to deal with these days -- or at any time.

Motley Fool 6 days ago

META

LLY

NFLX
Unpacking Q1 Earnings: Vertex Pharmaceuticals (NASDAQ:VRTX) In The Context Of Other Therapeutics Stocks

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how therapeutics stocks fared in Q1, starting with Vertex Pharmaceuticals (NASDAQ:VRTX).

StockStory 6 days ago

VRTX

UTHR

ABBV
VRTX Stock Down as Q1 Sales of New Drugs Miss Expectations

Sales from VRTX's new drugs, Casgevy, Alyftrek and Journavx, in Q1 fell short of investor expectations.

Zacks 8 days ago

VRTX
Why Vertex Pharmaceuticals Stock Is a Screaming Buy on the Dip

Vertex missed Wall Street's Q1 estimates and announced a pause with an early-stage study of its mRNA cystic fibrosis drug. This biotech stock should still generate exceptional returns over the next few years. Vertex Pharmaceuticals' (NASDAQ: VRTX) remarkable momentum came to a screeching halt this week.

Motley Fool 8 days ago

VRTX
1 S&P 500 Stock with Impressive Fundamentals and 2 to Ignore

The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are created equal - some are struggling with slowing growth, declining margins, or increased competition.

StockStory 8 days ago

^GSPC

VRTX

FAST
Stocks to Watch Recap: Palantir, Ford, Mattel, DoorDash

🔎 After-Market Activity: Super Micro Computer (SMCI) stock and Rivian Automotive (RIVN) shares fell after the companies released postmarket earnings, while Advanced Micro Devices (AMD) rose following its report.

The Wall Street Journal 8 days ago

VRTX

KLG

DASH
S&P 500 Gains & Losses Today: Stocks Fall for Second Day as Palantir, Pharmaceuticals Drop

The S&P 500 slipped 0.8% on Tuesday, May 6, 2025, falling for a second straight day as investors awaited news on U.S. tariff policies and prepared for tomorrow’s Federal Reserve announcement.

Investopedia 8 days ago

^GSPC

PLTR

VRTX
Vertex Pharmaceuticals Topples 10% On A Series Of First-Quarter Setbacks

Vertex stock skidded Tuesday on a series of first-quarter setbacks that included light sales, slow uptake for two drugs and a paused study.

Investor's Business Daily 8 days ago

VRTX
Why Did Vertex Pharmaceuticals Stock Fall On Tuesday?

On Monday, Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) reported lower-than-expected first-quarter 2025 earnings. Vertex reported first-quarter adjusted earnings per share of $4.06, down from $4.76 a year ago, missing the consensus of $4.32. The cystic fibrosis-focused company reported sales of $2.77 billion, missing the consensus of $2.85 billion. Total revenue increased by 3%, primarily driven by the continued performance of Trikafta/Kaftrio and an early contribution from the U.S. launch

Benzinga 8 days ago

VRTX

Performance Overview

Return	VX1.DE	S&P 500 (^GSPC)
YTD	-0.32%	+0.51%
1-Year	-3.47%	+11.36%
3-Year	+69.18%	+46.91%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Vertex Pharmaceuticals Incorporated (VX1.DE)

Are Investors Making a Big Mistake Dumping Shares of CRISPR Therapeutics?

Q1 Therapeutics Earnings: United Therapeutics (NASDAQ:UTHR) Impresses

2 Biotech Stocks That Are Screaming Buys in May

This Stock Just Dropped by 12% in 1 Day. History Says This Will Happen Next

Prediction: These 2 Stocks Will Outperform the Market in the Next Five Years

Can Buying CRISPR Therapeutics and Holding It Forever Make You a Millionaire?

Is Vertex Pharmaceuticals (VRTX) Among the Best Stocks to Buy According to Jim Simons’ Renaissance Technologies?

My Favorite Tariff Safe-Haven Stock to Buy on the Dip

Vertex Pharmaceuticals Incorporated (VRTX) Surged On a Recovery in Investor Sentiment

Vertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should Know

Vertex Pharmaceuticals Incorporated Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

4 No-Brainer Stocks to Buy Right Now

Unpacking Q1 Earnings: Vertex Pharmaceuticals (NASDAQ:VRTX) In The Context Of Other Therapeutics Stocks

VRTX Stock Down as Q1 Sales of New Drugs Miss Expectations

Why Vertex Pharmaceuticals Stock Is a Screaming Buy on the Dip

1 S&P 500 Stock with Impressive Fundamentals and 2 to Ignore

Stocks to Watch Recap: Palantir, Ford, Mattel, DoorDash

S&P 500 Gains & Losses Today: Stocks Fall for Second Day as Palantir, Pharmaceuticals Drop

Vertex Pharmaceuticals Topples 10% On A Series Of First-Quarter Setbacks

Why Did Vertex Pharmaceuticals Stock Fall On Tuesday?

Performance Overview